Literature DB >> 4428461

Acute pulmonary reaction to nitrofurantoin.

R F Pinerua, B J Hartnett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4428461      PMCID: PMC470207          DOI: 10.1136/thx.29.5.599

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  28 in total

1.  Loeffler's syndrome occurring during imipramine therapy.

Authors:  I C WILSON; J M GAMBILL; M G SANDIFER
Journal:  Am J Psychiatry       Date:  1963-03       Impact factor: 18.112

2.  Migratory pneumonia with eosinophilia associated with sulfonamide administration.

Authors:  D S Fiegenberg; H Weiss; H Kirshman
Journal:  Arch Intern Med       Date:  1967-07

3.  Acute pulmonary hypersensitivity to furazolidone.

Authors:  L M Cortez; G A Pankey
Journal:  Am Rev Respir Dis       Date:  1972-05

4.  Nitrofurantoin sensitivity. Report of a child with chronic inflammatory lung disease.

Authors:  R B David; H A Andersen; G B Stickler
Journal:  Am J Dis Child       Date:  1968-10

5.  Nitrofurantoin pulmonary reaction. A unique syndrome.

Authors:  T M Nicklaus; A B Snyder
Journal:  Arch Intern Med       Date:  1968-02

6.  Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin.

Authors:  M J Murray; R Kronenberg
Journal:  N Engl J Med       Date:  1965-11-25       Impact factor: 91.245

7.  Furadantin anaphylaxis.

Authors:  E J Satter
Journal:  J Urol       Date:  1966-07       Impact factor: 7.450

8.  Subacute pulmonary infiltration due to nitrofurantoin.

Authors:  P A Sollaccio; C A Ribaudo; W J Grace
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

9.  Nitrofurantoin pneumonia.

Authors:  W G Strauss; L M Griffin
Journal:  JAMA       Date:  1967-03-06       Impact factor: 56.272

10.  Loffler's syndrome: report of a case associated with administration of mephenesin carbamate (tolseram).

Authors:  T RODMAN; W FRAIMOW; R M MYERSON
Journal:  Ann Intern Med       Date:  1958-03       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.